Optimal Use of Biomarkers for Chronic Kidney Disease

Clin Chem. 2019 Aug;65(8):949-955. doi: 10.1373/clinchem.2018.299073. Epub 2019 May 23.

W Greg Miller¹, Lorin M Bachmann², Joris R Delanghe³, Lesley A Inker⁴, Graham R D Jones^{5

6}, Joseph A Vassalotti^{7

8}

¹ Professor of Pathology, Virginia Commonwealth University, Richmond, VA; greg.miller@vcuhealth.org.
² Associate Professor of Pathology, Virginia Commonwealth University, Richmond, VA.
³ Professor of Pathology, Ghent University Hospital, Belgium.
⁴ Associate Professor of Medicine, Tufts Medical Center, Boston, MA.
⁵ Chemical Pathologist, SydPath, St Vincent's Hospital Sydney, Kensington, Australia.
⁶ Associate Professor, University of New South Wales, Kensington, NSW, Australia.
⁷ National Kidney Foundation, New York, NY.
⁸ Clinical Associate Professor, Icahn School of Medicine at Mount Sinai, New York, NY.

No abstract available

Publication types